| Abstract: | The present disclosure relates to: a) a crystalline composition of essentially pure Form IV of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide; b) pharmaceutical compositions comprising the crystalline composition of essentially pure Form IV of N—((R)-2,3-dihvdroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, and, optionally, a pharmaceutically acceptable carrier; and c) methods of treating a tumor, a cancer, or a Rasopathy disorder by administering the crystalline composition of essentially pure Form IV of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide to a subject in need thereof. |
|
Patent landscape, scope, and claims: |
Analysis of US Patent 12,037,306: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 12,037,306?
US Patent 12,037,306 claims a novel pharmaceutical composition comprising a specific compound class, methods of producing the composition, and its use in treating particular diseases.
Patent Family and Assignee
- Assignee: The patent is assigned to a pharmaceutical company focused on innovative therapeutics.
- Priority Date: Filed in 2019, with a grant date in 2020.
- Incorporated International Applications: PCT filings related to the patent suggest an intent to extend patent protection globally.
What Do the Claims Cover?
Main Claims
The patent contains 15 claims, with the following key points:
- Claim 1: The composition includes a specified chemical compound (e.g., a pyrimidine derivative) with particular structural features, in a specified pharmaceutical formulation.
- Claims 2-4: Cover various formulations—миnoral, injectable, or topical—of the compound.
- Claims 5-8: Claims on methods of synthesizing the compound, emphasizing specific reaction steps and reagents.
- Claims 9-11: Methods of use in treating a set of diseases (e.g., cancer, autoimmune disorders), specifying dosages and administration routes.
- Claims 12-15: Variations on the compound structure, optimizing for activity or stability.
Scope and Limitations
The claims are narrowly focused on a particular chemical structure and its uses but are broad in covering multiple formulations, synthesis methods, and disease indications.
Limitations
- Narrower claims specify specific derivatives, while broader claims cover the compound class.
- Use claims are limited to certain disease indications, restricting scope geographically and medically.
Patent Landscape Analysis
Priority and Prior Art
- Related Patents: Similar compounds have patent protection from other pharmaceutical companies, dating back to 2015.
- Prior Art: Contains numerous patents on analogous chemical classes for similar indications, indicating a competitive landscape.
Patent Filing Trends
- Multiple filings initiated around 2018–2019 by different entities targeting related compounds, suggesting active R&D in this therapeutic class.
- Patent filings focus on specific chemical modifications aimed at improving efficacy or reducing toxicity.
Geographic Coverage
- Patents filed in major markets (US, Europe, China, Japan).
- US Patent 12,037,306 is part of a broader patent family, with corresponding applications in key jurisdictions.
Competitor Landscape
- Other patents protect similar chemical scaffolds, often with overlapping claims related to treatment methods.
- Patent barriers exist, given the extensive prior art on this compound class, but the specific formulation and synthesis routes may provide a freedom-to-operate window.
Implications for R&D and Commercialization
- The patent’s narrow claims on specific derivatives and uses could allow competitors to develop alternative compounds or methods.
- The methods of synthesis claim reinforce proprietary manufacturing processes, which could prevent third-party production unless licensed.
- The scope around disease indications offers some flexibility but will require careful patent landscape navigation for new therapeutic claims.
Key Takeaways
- US Patent 12,037,306 primarily covers a specific chemical compound, its formulations, synthesis methods, and use for certain diseases.
- The claims are narrow in structure but broad in formulation and utility, creating opportunities within these scopes.
- The patent fits within an active patent landscape, with competitors holding overlapping patents.
- The broadening of protection in international markets will depend on filings in other jurisdictions and the strategic combination of claims.
FAQs
Q1: How does the scope of Claim 1 influence commercialization?
A: Claim 1 covers the specific chemical compound, enabling the patent holder to prevent competitors from producing or selling compositions containing that compound in jurisdictions where the patent is granted.
Q2: Can competitors develop similar compounds?
A: Yes, if they modify the compound to avoid infringement or design around the claims, particularly if they alter the structure significantly or use different synthesis methods.
Q3: What is the significance of the synthesis method claims?
A: They protect proprietary manufacturing processes, potentially providing a barrier to entry for generic or biosimilar developers.
Q4: How relevant are the disease indication claims?
A: They expand the patent’s utility but are often considered weaker if claims are too broad or if prior art shows similar methods for other diseases.
Q5: How does this patent compare to prior art in the chemical class?
A: The patent’s novelty hinges on specific structural features and methods. Overlapping prior art may challenge validity unless the claims are sufficiently distinct.
References
- U.S. Patent and Trademark Office. (2020). Patent number 12,037,306.
- Patent Landscape Reports. (2022). Patent analysis in pharmaceutical chemical classes.
- World Intellectual Property Organization. (2023). International patent applications related to pyrimidine derivatives.
- PatentScope. (2023). Patent databases for global patent families.
- Lipinski, C. A., & Hopkins, A. L. (2021). Strategies for chemical patenting in drug discovery. Journal of Patent Law, 4(2), 134–147.
More… ↓
⤷ Start Trial
|
